Progyny, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Progyny, Inc. (PGNY) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.47 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-07
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 16.47M shares, a 2.89% decline year-over-year.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 16.78M shares, a 1.75% decline year-over-year.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 16.57M shares, a 2.67% decline year-over-year.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 16.96M shares, a 5.28% increase year-over-year.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 16.07M shares, a 0.48% increase from fiscal 2024.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 15.99M shares, a 22.87% increase from fiscal 2023.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 13.01M shares, a 33.45% increase from fiscal 2022.
- Progyny, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.75M shares, a 457.74% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.47M shares 10-Q · filed 2026-08-07 | 16.54M shares 10-Q · filed 2026-08-07 | |||||
| 2026-03-31 | 16.78M shares 10-Q · filed 2026-05-08 | ||||||
| 2025-12-31 | 16.07M shares 10-K · filed 2026-02-27 | ||||||
| 2025-09-30 | 16.57M shares 10-Q · filed 2025-11-07 | 16.52M shares 10-Q · filed 2025-11-07 | |||||
| 2025-06-30 | 16.96M shares 10-Q · filed 2026-08-07 | 17.02M shares 10-Q · filed 2026-08-07 | |||||
| 2025-03-31 | 17.08M shares 10-Q · filed 2026-05-08 | ||||||
| 2024-12-31 | 15.99M shares 10-K · filed 2026-02-27 | ||||||
| 2024-09-30 | 17.03M shares 10-Q · filed 2025-11-07 | 15.33M shares 10-Q · filed 2025-11-07 | |||||
| 2024-06-30 | 16.11M shares 10-Q · filed 2025-08-08 | 14.67M shares 10-Q · filed 2025-08-08 | |||||
| 2024-03-31 | 13.45M shares 10-Q · filed 2025-05-09 | ||||||
| 2023-12-31 | 13.01M shares 10-K · filed 2026-02-27 | ||||||
| 2023-09-30 | 12.98M shares 10-Q · filed 2024-11-12 | 12.93M shares 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | 13.04M shares 10-Q · filed 2024-08-07 | 13.35M shares 10-Q · filed 2024-08-07 | |||||
| 2023-03-31 | 13.50M shares 10-Q · filed 2024-05-10 | ||||||
| 2022-12-31 | 9.75M shares 10-K · filed 2025-03-03 | ||||||
| 2022-09-30 | 8.81M shares 10-Q · filed 2023-11-08 | 9.09M shares 10-Q · filed 2023-11-08 | |||||
| 2022-06-30 | 9.57M shares 10-Q · filed 2023-08-04 | 9.19M shares 10-Q · filed 2023-08-04 | |||||
| 2022-03-31 | 8.66M shares 10-Q · filed 2023-05-09 | ||||||
| 2021-12-31 | 1.75M shares 10-K · filed 2024-02-29 | ||||||
| 2021-09-30 | 1.24M shares 10-Q · filed 2022-11-04 | 889.44K shares 10-Q · filed 2022-11-04 | |||||
| 2021-06-30 | 1.02M shares 10-Q · filed 2022-08-05 | 1.02M shares 10-Q · filed 2021-08-06 | 709.46K shares 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | 395.67K shares 10-Q · filed 2022-05-06 | ||||||
| 2020-12-31 | 769.42K shares 10-K · filed 2023-03-01 | ||||||
| 2020-09-30 | 737.48K shares 10-Q · filed 2021-11-08 | 578.05K shares 10-Q · filed 2021-11-08 | 578.05M shares 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | 12.47M shares 10-Q · filed 2021-08-06 | 496.57K shares 10-Q · filed 2021-08-06 | 496.57M shares 10-Q · filed 2020-08-07 | ||||
| 2020-03-31 | 372.42K shares 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | 13.73M shares 10-K · filed 2022-03-01 | ||||||
| 2019-09-30 | 79.70M shares 10-Q · filed 2020-11-06 | 78.26B shares 10-Q · filed 2020-11-06 | 78.26M shares 10-Q · filed 2019-12-06 | ||||
| 2019-06-30 | 78.23M shares 10-Q · filed 2020-08-07 | 77.64B shares 10-Q · filed 2020-08-07 | |||||
| 2019-03-31 | 76.54M shares 10-Q · filed 2020-05-14 | ||||||
| 2018-12-31 | 72.31M shares 10-K · filed 2021-03-01 | ||||||
| 2018-09-30 | 71.68M shares 10-Q · filed 2019-12-06 | 70.54M shares 10-Q · filed 2019-12-06 | |||||
| 2017-12-31 | 62.43M shares 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |